Skip to main content
DNA Labs India

ARHGEF9 Gene Early infantile epileptic encephalopathy type 8 NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

ARHGEF9 Gene Early infantile epileptic encephalopathy type 8 NGS Genetic Test

Short Name: ARHGEF9 Gene EIEE8 NGS Test

Also known as: ARHGEF9 NGS Test, EIEE8 Genetic Test, ARHGEF9 Gene Sequencing

ARHGEF9 Gene Early infantile epileptic encephalopathy type 8 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in 3 to 4 weeks after the laboratory receives the sample.. Free home collection in 300+ cities across India.

NGS Genetic TestInfants and children; adult carrier/family testing with clinical indication🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this test is to confirm or exclude a molecular diagnosis of Early Infantile Epileptic Encephalopathy type 8 caused by ARHGEF9 gene variants. It also helps guide treatment decisions, prognosis, and recurrence-risk counselling for the family.

Test Code
4046
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
3 to 4 weeks after the laboratory receives the sample.
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

No fasting is required. The doctor or genetic counsellor will record the clinical history and family history. Informed consent should be obtained before testing.

Method: Peripheral blood draw / FTA card blood spot / submitted DNA sample

Step 2

Laboratory Analysis

A small blood sample is collected in an EDTA tube, or one drop of blood is placed on an FTA card. Extracted DNA may also be submitted if available.

Step 3

Report Delivery

No special precautions are needed. The sample is transported to the laboratory under recommended conditions for NGS analysis.

Timeline: 3 to 4 weeks after the laboratory receives the sample.

Patient Instructions

1
Before the Test:Discuss the test with a doctor or genetic counsellor. Provide family history and bring any previous medical or EEG records.
2
During the Test:The sample collection is quick. Blood or FTA card sample is taken as per the laboratory protocol.
3
After the Test:No restrictions. Wait for the report, which usually takes 3 to 4 weeks. A post-test genetic counselling session may be recommended to understand the result.

About This Test

Who Should Get This Test

The purpose of this test is to confirm or exclude a molecular diagnosis of Early Infantile Epileptic Encephalopathy type 8 caused by ARHGEF9 gene variants. It also helps guide treatment decisions, prognosis, and recurrence-risk counselling for the family.

How to Prepare

  • Submit a properly labelled sample with patient name, date of birth, and clinical indication
  • Provide the completed clinical history and pedigree chart from the genetic counselling session
  • Inform the laboratory if the patient has received a blood transfusion recently, if relevant

Doctor's Notes

Reviewed by — MBBS, MD (Pathology) · Reg. No. 21521

"Genetic counselling should always accompany epilepsy gene panel testing, especially in Early Infantile Epileptic Encephalopathy, to help families understand inheritance pattern and recurrence risk."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample VolumeAs per laboratory collection kit
ContainerEDTA tube / FTA card / DNA vial
Collection MethodPeripheral blood draw / FTA card blood spot / submitted DNA sample

Sample Stability

EDTA blood: Stable for up to 72 hours at 2–8°C
FTA card: Stable at ambient room temperature
Extracted DNA: Stable at -20°C or lower for long-term storage
Sample Rejection Criteria:
  • Hemolyzed, clotted, or visibly degraded blood sample
  • Insufficient sample volume or quantity of DNA
  • Unlabelled or mismatched sample
  • Sample received without the completed test request form

Understanding Your Results

The ARHGEF9 NGS genetic test is interpreted using ACMG/AMP guidelines. The report identifies pathogenic, likely pathogenic, or other clinically relevant variants in the ARHGEF9 gene and selected EIEE-related genes included in the analysis.
Negative: No disease-causing variant identified in ARHGEF9.
Positive: A pathogenic/likely pathogenic variant identified in ARHGEF9 confirms the diagnosis of EIEE type 8.
Variant of uncertain significance (VUS): A genetic variant was found but its clinical significance is unclear; further family testing and a clinical geneticist review may be needed.
⚠️ When to Consult a Doctor:

If your child has repeated seizures, developmental delay, low muscle tone, poor feeding, or a family history of genetic epilepsy, consult a paediatric neurologist or clinical geneticist for evaluation.

Limitations

  • NGS may not detect large structural rearrangements, repeat expansions, or deep intronic variants unless specifically validated
  • Variants of uncertain significance may require additional family-segregation studies
  • A negative result does not exclude all genetic or non-genetic causes of EIEE

Risks & Considerations

  • No significant risk from a routine blood draw; mild bruising or pain at the collection site may occur rarely
  • In rare cases, an insufficient sample may require a repeat collection

Interfering Factors

  • Inadequate or degraded DNA
  • Contamination of the sample during collection or handling
  • Incorrect sample labeling
  • Presence of a maternal cell admixture in neonatal blood samples

Compare With Similar Tests

TestARHGEF9 Gene Early infantile epileptic encephalopathy type 8 NGS Genetic Test
ComparisonARHGEF9 Gene Early infantile epileptic encephalopathy type 8 NGS Genetic TestTargets ARHGEF9 and relevant EIEE genes simultaneously, suitable for etiologic diagnosis of EIEE type 8.Best used to confirm a known familial variant; not ideal for screening multiple epilepsy genes at once.Detects large copy-number changes and deletions/duplications, but cannot detect small sequence variants in ARHGEF9.

Frequently Asked Questions

What is the cost of the ARHGEF9 gene EIEE type 8 NGS genetic test?
The ARHGEF9 gene early infantile epileptic encephalopathy type 8 NGS genetic test costs INR 20,000 at DNA Labs India. Online bookings receive free home sample collection in eligible cities.
Which sample is needed for this test?
The test can be done on blood, extracted DNA, or one drop of blood on an FTA card.
Is fasting required before the test?
No, fasting is not required for this genetic test. You can follow your regular diet unless the doctor advises otherwise.
How is the test performed?
DNA is extracted from the sample, and next-generation sequencing is used to look for mutations in the ARHGEF9 gene and relevant EIEE-related genes.
What is the ARHGEF9 gene?
The ARHGEF9 gene provides instructions for making a protein important for brain development and function. Pathogenic variants in this gene are linked to EIEE type 8.
What is early infantile epileptic encephalopathy type 8?
EIEE type 8 is a rare and severe epilepsy syndrome that begins in early infancy. It is caused by mutations in the ARHGEF9 gene and is marked by seizures, developmental delay, intellectual disability, poor feeding, and muscle tone abnormalities.
How long does the report take?
Reports are generally available within 3 to 4 weeks after the sample is received by the laboratory.
Will this test detect other causes of EIEE?
The NGS panel can include other EIEE-related genes depending on panel design. However, the primary target is the ARHGEF9 gene, and the report is focused on clinically relevant findings for EIEE type 8.
Is genetic counselling needed before this test?
Yes. A pre-test genetic counselling session is recommended to draw a family pedigree and discuss inheritance, limitations, and implications of the result.
Can the test be done at home?
DNA Labs India offers free home sample collection for online bookings in many cities across India. The phlebotomist will collect the blood or FTA card sample from your home.
How accurate is NGS genetic testing for EIEE type 8?
NGS is highly accurate for detecting small sequence variants in the ARHGEF9 gene. A detected variant may be confirmed by Sanger sequencing if needed.
What if the test result is negative but symptoms continue?
A negative result means no disease-causing ARHGEF9 variant was identified. A paediatric neurologist or clinical geneticist should investigate other genetic or non-genetic causes of the symptoms.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.